Research Report Explores the Oxygen Therapy Market for the Forecast Period, 2016-2024

Oxygen therapy is administered by use of oxygen gas as a medical intervention given acute or chronic patient care as it is essential for various cell metabolism whereas tissue oxygenation is essential for normal physiological function. Oxygen therapy is administered when the oxygen levels in blood is low. It can be administered in various ways from nasal to hyperbaric oxygen in a closed chamber. To understand how oxygen therapy is implemented in use, we need to understand the respiratory system. The respiratory system is a group of organs and tissues that help in breathing.

The lungs and the nasal tract along with the wind pipe together form the respiratory system. The air enters the body through nose or mouth through the wind pipe to the lungs via bronchi. The bronchi branches out into several tubes called bronchioles, which further branch out into tiny air sacs known as alveoli. These tiny air sacs are covered with a mesh of blood vessels called capillaries, which are connected to several arteries and veins which transfer oxygen throughout the body. Certain acute or chronic disease conditions, which affect the transfer of oxygen from alveoli to the blood, such a pneumonia, cystic fibrosis, asthma, dysplasia, heart failure, sleep apnea, lung disorders, and COPD (chronic obstructive pulmonary disease). Oxygen therapy is administered on the basis of arterial blood gas test and a pulse oximetry test.

Request for Report TOC @ https://www.persistencemarketresearch.com/toc/11959

According to the World Health Organization (WHO), total deaths due to COPD is expected to rise approximately by 30% in the next decade, thereby driving the need to incorporate oxygen therapy as a treatment option. However it is estimated that COPD will be the third most fatal disease worldwide by 2024, thereby widening the consumer base for oxygen therapy market. The growing demand for technologically advanced system, such as portable oxygen concentrator system has also boosted global oxygen therapy market growth. Some of the major advancements include pulse oximetry devices, and nasopharyngeal oxygen therapy.

Major benefits of oxygen therapy are decreasing shortness of breath and fatigue, it helps people with sleep disorders and increases the lifespan of individuals with COPD. Depending on the need, oxygen therapy devices can purchased through insurance companies.

On the basis of regional presence, global oxygen therapy market is segmented into five key regions viz. North America, Latin America, Europe, Asia-Pacific-Pacific, and Middle East & Africa. North America is expected to lead the global Oxygen Therapy testing market due to high prevalence of respiratory related diseases, increase in number of product approval, increase in aging population, increase in vulnerability to respiratory conditions, innovation in portable oxygen concentrators, rise in number of untreated sleep apnea cases, growing demand for oxygen filling devices and high RnD investment are driving the growth of oxygen therapy market in the region. European market is also closely competing in terms of revenue generation because of favorable government initiatives taken for respiratory care.

The oxygen therapy market in Asia-Pacific Pacific region is expected to witness a rise in growth opportunities due to an increase in geriatric population requiring home-based oxygen therapy, and rising healthcare expenditure. The other major restraining factor for growth of oxygen therapy market have been strict regulatory approval policies and complicated reimbursement process.

Request for Report Sample @ https://www.persistencemarketresearch.com/samples/11959

Some key players involved in oxygen therapy market are Care Fusion Corp., GE Healthcare, Hersill, Philips Respironics, Inc., De-Vilbiss Healthcare, MAQUET Medical Systems, Smiths Medical, Allied Healthcare Products, Fisher & Paykel Healthcare Limited, Teleflex Incorporated, and Invacare Corporation.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact Us

Persistence Market Research
305 Broadway,7th Floor
New York City, NY 10007
United States
Tel: +1-646-568-7751
Tollfree: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Website: https://www.persistencemarketresearch.com

This release was published on openPR.